First Time Loading...

Sangamo Therapeutics Inc
NASDAQ:SGMO

Watchlist Manager
Sangamo Therapeutics Inc Logo
Sangamo Therapeutics Inc
NASDAQ:SGMO
Watchlist
Price: 0.5614 USD 7.26% Market Closed
Updated: May 12, 2024

Sangamo Therapeutics Inc
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sangamo Therapeutics Inc
Income to Minority Interest Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Sangamo Therapeutics Inc
NASDAQ:SGMO
Income to Minority Interest
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Income to Minority Interest
-$10m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Income to Minority Interest
$26m
CAGR 3-Years
-2%
CAGR 5-Years
54%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sangamo Therapeutics Inc's Income to Minority Interest?
Income to Minority Interest
0 USD

Based on the financial report for Dec 31, 2023, Sangamo Therapeutics Inc's Income to Minority Interest amounts to 0 USD.